Burosumab Therapy in Children with X-Linked HypophosphatemiaThomas O. Carpenter, Anthony A. Portale, Michael P. Whyte et al.|New England Journal of Medicine|2018Cited by 479
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Stuart J. Swiedler, Kenneth I. Berger et al.|The Journal of Pediatrics|2006Cited by 364
Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IEmil Kakkis, Merry Passage, Michael F. McEntee et al.|Molecular Genetics and Metabolism|2004Cited by 168
Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluidPatricia Dickson, Emil Kakkis, Michael F. McEntee et al.|Molecular Genetics and Metabolism|2007Cited by 162
Mannose 6-Phosphate Conjugation Is Not Sufficient to Allow Induction of Immune Tolerance to Phenylalanine Ammonia-Lyase in DogsMoin Vera, Patricia Dickson, Thomas Lester et al.|JIMD Reports|2012Cited by 3